OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The potential of using blood circular RNA as liquid biopsy biomarker for human diseases
Guoxia Wen, Tong Zhou, Wanjun Gu
Protein & Cell (2020) Vol. 12, Iss. 12, pp. 911-946
Open Access | Times Cited: 140

Showing 1-25 of 140 citing articles:

Crosstalk between circRNAs and the PI3K/AKT signaling pathway in cancer progression
Chen Xue, Ganglei Li, Juan Lü, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 146

Circular RNAs: characteristics, biogenesis, mechanisms and functions in liver cancer
Hao Shen, Boqiang Liu, Junjie Xu, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 104

Exosomal circular RNAs: A chief culprit in cancer chemotherapy resistance
Xu Guo, Congying Gao, Dong‐Hua Yang, et al.
Drug Resistance Updates (2023) Vol. 67, pp. 100937-100937
Closed Access | Times Cited: 101

Review: RNA-based diagnostic markers discovery and therapeutic targets development in cancer
Hongbo Wang, Qinghai Meng, Jinjun Qian, et al.
Pharmacology & Therapeutics (2022) Vol. 234, pp. 108123-108123
Closed Access | Times Cited: 81

Circular RNA in cancer
Vanessa M. Conn, Arul M. Chinnaiyan, Simon J. Conn
Nature reviews. Cancer (2024) Vol. 24, Iss. 9, pp. 597-613
Closed Access | Times Cited: 40

CircRNAs and their regulatory roles in cancers
Mei Tao, Ming Zheng, Yanhua Xu, et al.
Molecular Medicine (2021) Vol. 27, Iss. 1
Open Access | Times Cited: 82

CircDOCK1 promotes the tumorigenesis and cisplatin resistance of osteogenic sarcoma via the miR-339-3p/IGF1R axis
Shenglong Li, Fei Liu, Ke Zheng, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 70

Circular RNAs’ cap-independent translation protein and its roles in carcinomas
Lian He, Changfeng Man, Shouyan Xiang, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 69

Engineered extracellular vesicles for bone therapy
Yingying Jiang, Jiadong Li, Xue Xu, et al.
Nano Today (2022) Vol. 44, pp. 101487-101487
Closed Access | Times Cited: 57

Exosomal circRNAs in cancer: Implications for therapy resistance and biomarkers
Zhengjun Lin, Yuqiao Ji, Jian Zhou, et al.
Cancer Letters (2023) Vol. 566, pp. 216245-216245
Closed Access | Times Cited: 37

CircFBXW4 Suppresses Colorectal Cancer Progression by Regulating the MiR‐338‐5p/SLC5A7 Axis
Wei Song, Jincheng Fu, Jing Wu, et al.
Advanced Science (2024) Vol. 11, Iss. 18
Open Access | Times Cited: 9

Circular RNAs in tumor immunity and immunotherapy
Wenjie Zhang, Xu Chen, Zhipeng Yang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 9

The Emerging Role of Blood-Based Biomarkers in Early Detection of Colorectal Cancer: A Systematic Review
Faris Shweikeh, Yuhao Zeng, Abdur Rahman Jabir, et al.
Cancer Treatment and Research Communications (2025), pp. 100872-100872
Open Access | Times Cited: 1

Circular RNAs as Potential Biomarkers in Breast Cancer
Fatima Domenica Elisa De Palma, Francesco Salvatore, Jonathan Pol, et al.
Biomedicines (2022) Vol. 10, Iss. 3, pp. 725-725
Open Access | Times Cited: 35

Novel insights into the interaction between N6-methyladenosine modification and circular RNA
Tao Xu, Bangshun He, Huiling Sun, et al.
Molecular Therapy — Nucleic Acids (2022) Vol. 27, pp. 824-837
Open Access | Times Cited: 33

The novel role of circular RNA ST3GAL6 on blocking gastric cancer malignant behaviours through autophagy regulated by the FOXP2/MET/mTOR axis
Penghui Xu, Xing Zhang, Jiacheng Cao, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 33

CircRNA–miRNA interactions in atherogenesis
Kind-Leng Tong, Ke‐En Tan, Yat‐Yuen Lim, et al.
Molecular and Cellular Biochemistry (2022) Vol. 477, Iss. 12, pp. 2703-2733
Closed Access | Times Cited: 28

The novel β-TrCP protein isoform hidden in circular RNA confers trastuzumab resistance in HER2-positive breast cancer
Shengting Wang, Yufang Wang, Qian Li, et al.
Redox Biology (2023) Vol. 67, pp. 102896-102896
Open Access | Times Cited: 21

Peripheral blood mononuclear cell derived biomarker detection using eXplainable Artificial Intelligence (XAI) provides better diagnosis of breast cancer
Sunil Kumar, Asmita Das
Computational Biology and Chemistry (2023) Vol. 104, pp. 107867-107867
Closed Access | Times Cited: 18

The Analysis of Platelet-Derived circRNA Repertoire as Potential Diagnostic Biomarker for Non-Small Cell Lung Cancer
Silvia D’Ambrosi, Allerdien Visser, Mafalda Antunes‐Ferreira, et al.
Cancers (2021) Vol. 13, Iss. 18, pp. 4644-4644
Open Access | Times Cited: 36

Circular RNA in disease: Basic properties and biomedical relevance
Xiaolan Chen, Min Zhou, Levi Yant, et al.
Wiley Interdisciplinary Reviews - RNA (2022) Vol. 13, Iss. 6
Closed Access | Times Cited: 28

Circulating Exosomal circRNAs Contribute to Potential Diagnostic Value of Large Artery Atherosclerotic Stroke
Qi Xiao, Rongyao Hou, Hong Li, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 27

Hypoxia-induced circADAMTS6 in a TDP43-dependent manner accelerates glioblastoma progression via ANXA2/ NF-κB pathway
Shulin Zhao, Boyan Li, Rongrong Zhao, et al.
Oncogene (2022) Vol. 42, Iss. 2, pp. 138-153
Closed Access | Times Cited: 26

Therapeutic and diagnostic applications of exosomal circRNAs in breast cancer
Mohanraj Gopikrishnan, Hephzibah Cathryn R, Gnanasambandan Ramanathan, et al.
Functional & Integrative Genomics (2023) Vol. 23, Iss. 2
Open Access | Times Cited: 15

Page 1 - Next Page

Scroll to top